Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody− calicheamicin conjugate for treatment of acute myeloid leukemia

PR Hamann, LM Hinman, I Hollander… - Bioconjugate …, 2002 - ACS Publications
CD33 is expressed by acute myeloid leukemia (AML) cells in> 80% of patients but not by
normal hematopoietic stem cells, suggesting that elimination of CD33+ cells may be …
被引用次数：772 相关文章

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.

PR Hamann, LM Hinman, I Hollander… - Bioconjugate …, 2002 - europepmc.org
CD33 is expressed by acute myeloid leukemia (AML) cells in> 80% of patients but not by
normal hematopoietic stem cells, suggesting that elimination of CD33 (+) cells may be …

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia

PR Hamann, LM Hinman, I Hollander… - Bioconjugate …, 2002 - pubmed.ncbi.nlm.nih.gov
CD33 is expressed by acute myeloid leukemia (AML) cells in> 80% of patients but not by
normal hematopoietic stem cells, suggesting that elimination of CD33 (+) cells may be …

[引用][C] Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody− Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia

PR Hamann, LM Hinman, I Hollander, CF Beyer… - Bioconjugate …, 2002 - infona.pl
Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin
Conjugate for Treatment of Acute Myeloid Leukemia × Close The Infona portal uses cookies, ie …

[引用][C] Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody− Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia

PR Hamann, LM Hinman, I Hollander, CF Beyer… - Bioconjugate …, 2001 - cir.nii.ac.jp
Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin
Conjugate for Treatment of Acute Myeloid Leukemia | CiNii Research CiNii 国立情報学研究所 …

[引用][C] Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia

H PR - Bioconjug Chem, 2002 - cir.nii.ac.jp
Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin
conjugate for treatment of acute myeloid leukemia | CiNii Research CiNii 国立情報学研究所 …

[引用][C] Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia

PR HAMANN, LM HINMAN… - Bioconjugate …, 2002 - American Chemical Society